Clinical studies have shown that probiotics positively affect oral health by decreasing gum bleeding and/or reducing salivary counts of certain oral pathogens. Our aim was to investigate the inhibitory effect of six probiotic lactobacilli against opportunistic oral Candida species. Sugar utilisation by both lactobacilli and Candida was also assessed. Agar overlay assay was utilised to study growth inhibition of Candida albicans, Candida glabrata and Candida krusei by Lactobacillus rhamnosus GG, Lactobacillus casei Shirota, Lactobacillus reuteri SD2112, Lactobacillus brevis CD2, Lactobacillus bulgaricus LB86 and L. bulgaricus LB Lact. The inhibitory effect was measured at pH 5.5, 6.4, and 7.2, respectively, and in the presence of five different carbohydrates in growth medium (glucose, fructose, lactose, sucrose, and sorbitol). Growth and final pH values were measured at two-hour time points to 24 h. L. rhamnosus GG showed the strongest inhibitory activity in fructose and glucose medium against C. albicans, followed by L. casei Shirota, L. reuteri SD2112 and L. brevis CD2. None of the lactobacilli tested affected the growth of C. krusei. Only L. rhamnosus GG produced slight inhibitory effect on C. glabrata. The lower pH values led to larger inhibition zones. Sugar fermentation profiles varied between the strains. L. casei Shirota grew in the presence of all sugars tested, whereas L. brevis CD2 could utilise only glucose and fructose. All Candida species metabolised the available sugars but the most rapid growth was observed with C. glabrata. The results suggest that commercially available probiotics differ in their inhibitory activity and carbohydrate utilisation; the above properties are modified by different pH values and sugars with more pronounced inhibition at lower pH.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Akins, R.A., 2005. An update on antifungal targets and mechanisms of resistance in Candida albicans. Medical Mycology 43: 285-318.
'An update on antifungal targets and mechanisms of resistance in Candida albicans ' () 43 Medical Mycology : 285 -318.
Axelsson, L.T., Chung, T.C., Dobrogosz, W.J. and Lindgren, S.E., 1989. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecology in Health and Disease 2: 131-136.
'Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri ' () 2 Microbial Ecology in Health and Disease : 131 -136.
Basson, N.J., 2000. Competition for glucose between Candida albicans and oral bacteria grown in mixed culture in a chemostat. Journal of Medical Microbiology 49: 969-975.
'Competition for glucose between Candida albicans and oral bacteria grown in mixed culture in a chemostat ' () 49 Journal of Medical Microbiology : 969 -975.
Cannon, R.D., Lamping, E., Holmes, A.R., Niimi, K., Tanabe, K., Niimi, M. and Monk, B.C., 2007. Candida albicans drug resistance another way to cope with stress. Microbiology 153: 3211-3217.
'Candida albicans drug resistance another way to cope with stress ' () 153 Microbiology : 3211 -3217.
Cartledge, J.D., Midgley, J. and Gazzard, B.G., 1999. Non-albicans oral candidosis in HIV-positive patients. Journal of Antimicrobial Chemotherapy 43: 419-422.
'Non-albicans oral candidosis in HIV-positive patients ' () 43 Journal of Antimicrobial Chemotherapy : 419 -422.
Chuang, L.C., Huang, C.S., Ou-Yang, L.W. and Lin, S.Y., 2011. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora. Clinical Oral Investigations 15: 471-476.
'Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora ' () 15 Clinical Oral Investigations : 471 -476.
DebMandal, M., Mandal, S. and Pal, N.K., 2012. Detection of intestinal colonization of probiotic Lactobacillus rhamnosus by stool culture in modified selective media. Asian Pacific Journal of Tropical Diseases 2012: 205-210.
'Detection of intestinal colonization of probiotic Lactobacillus rhamnosus by stool culture in modified selective media ' () 2012 Asian Pacific Journal of Tropical Diseases : 205 -210.
Elahi, S., Pang, G., Ashman, R. and Clancy, R., 2005. Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clinical and Experimental Immunology 141: 29-36.
'Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus ' () 141 Clinical and Experimental Immunology : 29 -36.
Hasslöf, P., Hedberg, M., Twetman, S. and Stecksén-Blicks, C., 2010. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study. BMC Oral Health 10: 18.
'Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study ' () 10 BMC Oral Health : 18.
Hatakka, K., Ahola, A.J., Yli-Knuuttila, H., Richardson, M., Poussa, T., Meurman, J.H. and Korpela, R., 2007. Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial. Journal of Dental Research 86: 125-130.
'Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial ' () 86 Journal of Dental Research : 125 -130.
Haukioja, A., Söderling, E. and Tenovuo, J., 2008. Acid production from sugars and sugar alcohols by probiotic lactobacilli and bifidobacteria in vitro. Caries Research 42: 449-453.
'Acid production from sugars and sugar alcohols by probiotic lactobacilli and bifidobacteria in vitro ' () 42 Caries Research : 449 -453.
Hawser, S.P. and Douglas, L.J., 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrobial Agents and Chemotherapy 39: 2128-2131.
'Resistance of Candida albicans biofilms to antifungal agents in vitro ' () 39 Antimicrobial Agents and Chemotherapy : 2128 -2131.
Hope, W., Morton, A. and Eisen, D.P., 2002. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. Journal of Hospital Infection 50: 56-65.
'Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use ' () 50 Journal of Hospital Infection : 56 -65.
Kékessy, D.A. and Piguet, J.D., 1970. New method for detecting bacteriocin production. Journal of Applied Microbiology 20: 282-283.
'New method for detecting bacteriocin production ' () 20 Journal of Applied Microbiology : 282 -283.
Keller, M.K., Hasslöf, P., Stecksén-Blicks, C. and Twetman, S., 2011. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study. Acta Odontologica Scandinavica 69: 263-268.
'Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study ' () 69 Acta Odontologica Scandinavica : 263 -268.
Köhler, G.A., Assefa, S. and Reid, G., 2012. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infectious Diseases in Obstetrics and Gynecology 2012: 636474.
'Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans ' () 2012 Infectious Diseases in Obstetrics and Gynecology : 636474.
Kõll, P., Mändar, R., Marcotte, H., Leibur, E., Mikelsaar, M. and Hammarström, L., 2008. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiology and Immunology 23: 139-147.
'Characterization of oral lactobacilli as potential probiotics for oral health ' () 23 Oral Microbiology and Immunology : 139 -147.
Li, L., Redding, S. and Dongari-Bagtzoglou, A., 2007. Candida glabrata: an emerging oral opportunistic pathogen. Journal of Dental Research 86: 204-215.
'Candida glabrata: an emerging oral opportunistic pathogen ' () 86 Journal of Dental Research : 204 -215.
Lidstrom, M.E. and Konopka, M.C., 2010. The role of physiological heterogeneity in microbial population behavior. Nature Chemical Biology 6: 705-712.
'The role of physiological heterogeneity in microbial population behavior ' () 6 Nature Chemical Biology : 705 -712.
Maekawa, T. and Hajishengallis, G., 2014. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. Journal of Periodontal Research, in press. DOI: http://dx.doi.org/10.1111/jre.12164.
Meurman, J.H. and Ten Cate, J.M., 1996. Pathogenesis and modifying factors of dental erosion. European Journal of Oral Sciences 104: 199-206.
'Pathogenesis and modifying factors of dental erosion ' () 104 European Journal of Oral Sciences : 199 -206.
Meurman, J.H., Siikala, E., Richardson, M. and Rautemaa, R., 2007. Non-Candida albicans Candida yeasts of the oral cavity. In: Méndez-Vilas, A. (ed.) Communicating current research and educational topics and trends in applied microbiology. Formatex, Badajoz, Spain, pp. 719-731.
Communicating current research and educational topics and trends in applied microbiology , () 719 -731.
Moran, G.P., Sullivan, D.J. and Coleman, D.C., 2002. Emergence of non-Candida albicans Candida species as pathogens. In: Calderone, R.A. (ed.) Candida and candidiasis, 4th ed. ASM Press, Washington, DC, USA, pp. 37-53.
Candida and candidiasis , () 37 -53.
Payne, S., Gibson, G., Wynne, A., Hudspith, B., Brostoff, J. and Tuohy, K., 2003. in vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Current Issues in Intestinal Microbiology 4: 1-8.
'in vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK ' () 4 Current Issues in Intestinal Microbiology : 1 -8.
Redding, S.W., Kirkpatrick, W.R., Coco, B.J., Sadkowski, L., Fothergill, A.W., Rinaldi, M.G., Eng, T.Y. and Patterson, T.F., 2002. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. Journal of Clinical Microbiology 40: 1879-1881.
'Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer ' () 40 Journal of Clinical Microbiology : 1879 -1881.
Scully, C., 2013. Oral and maxillofacial medicine, 3rd ed. Churchill Livingstone Publishing, London, UK, 255 pp.
Oral and maxillofacial medicine , ().
Scully, C., El-Kabir, M. and Samaranayake, L.P., 1994. Candida and oral candidosis: a review. Critical Reviews in Oral Biology and Medicine 5: 125-157.
'Candida and oral candidosis: a review ' () 5 Critical Reviews in Oral Biology and Medicine : 125 -157.
Seneviratne, C.J., Jin, L. and Samaranayake, L.P., 2008. Biofilm lifestyle of Candida: a mini review. Oral Diseases 14: 582-590.
'Biofilm lifestyle of Candida: a mini review ' () 14 Oral Diseases : 582 -590.
Seneviratne, C.J., Wong, S.S., Yuen, K.Y., Meurman, J.H., Pärnänen, P., Vaara, M. and Samaranayake, L.P., 2011. Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland. Mycopathologia 172: 389-395.
'Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland ' () 172 Mycopathologia : 389 -395.
Simark-Mattsson, C., Jonsson, R., Emilson, C.G. and Roos, K., 2009. Final pH affects the interference capacity of naturally occurring oral Lactobacillus strains against mutans streptococci. Archives of Oral Biology 54: 602-607.
'Final pH affects the interference capacity of naturally occurring oral Lactobacillus strains against mutans streptococci ' () 54 Archives of Oral Biology : 602 -607.
Söderling, E.M., Marttinen, A.M. and Haukioja, A.L., 2011. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro. Current Microbiology 62: 618-622.
'Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro ' () 62 Current Microbiology : 618 -622.
Stamatova, I., Kari, K. and Meurman, J.H., 2012. Dietary sugar utilisation by putative oral probiotics. Beneficial Microbes 3: 221-227.
'Dietary sugar utilisation by putative oral probiotics ' () 3 Beneficial Microbes : 221 -227.
Stamatova, I., Meurman, J.H., Kari, K., Tervahartiala, T., Sorsa, T. and Baltadjieva, M., 2007. Safety issues of Lactobacillus bulgaricus with respect to human gelatinases in vitro. FEMS Immunology and Medical Microbiology 51: 194-200.
'Safety issues of Lactobacillus bulgaricus with respect to human gelatinases in vitro ' () 51 FEMS Immunology and Medical Microbiology : 194 -200.
Strus, M., Kucharska, A., Kukla, G., Brzychczy-Włoch, M., Maresz, K. and Heczko, P.B., 2005. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infectious Diseases in Obstetrics and Gynecology 13: 69-75.
'The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida ' () 13 Infectious Diseases in Obstetrics and Gynecology : 69 -75.
Twetman, S. and Keller, M.K., 2012. Probiotics for caries prevention and control. Advances in Dental Research 24: 98-102.
'Probiotics for caries prevention and control ' () 24 Advances in Dental Research : 98 -102.
Young, G., Krasner, R.I. and Yudkofsky, P.L., 1956. Interactions of oral strains of Candida albicans and lactobacilli. Journal of Bacteriology 72: 525-529.
'Interactions of oral strains of Candida albicans and lactobacilli ' () 72 Journal of Bacteriology : 525 -529.
Thein, Z.M., Samaranayake, Y.H. and Samaranayake, L.P., 2006. Effect of oral bacteria on growth and survival of Candida albicans biofilm. Archives of Oral Biology 51(8): 672-680.
'Effect of oral bacteria on growth and survival of Candida albicans biofilm ' () 51 Archives of Oral Biology : 672 -680.
Thein, Z.M., Samaranayake, Y.H. and Samaranayake L.P., 2007. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Archives of Oral Biology 52(8): 761-767.
'In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions ' () 52 Archives of Oral Biology : 761 -767.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 688 | 289 | 33 |
| Full Text Views | 45 | 27 | 1 |
| PDF Views & Downloads | 27 | 12 | 3 |
Clinical studies have shown that probiotics positively affect oral health by decreasing gum bleeding and/or reducing salivary counts of certain oral pathogens. Our aim was to investigate the inhibitory effect of six probiotic lactobacilli against opportunistic oral Candida species. Sugar utilisation by both lactobacilli and Candida was also assessed. Agar overlay assay was utilised to study growth inhibition of Candida albicans, Candida glabrata and Candida krusei by Lactobacillus rhamnosus GG, Lactobacillus casei Shirota, Lactobacillus reuteri SD2112, Lactobacillus brevis CD2, Lactobacillus bulgaricus LB86 and L. bulgaricus LB Lact. The inhibitory effect was measured at pH 5.5, 6.4, and 7.2, respectively, and in the presence of five different carbohydrates in growth medium (glucose, fructose, lactose, sucrose, and sorbitol). Growth and final pH values were measured at two-hour time points to 24 h. L. rhamnosus GG showed the strongest inhibitory activity in fructose and glucose medium against C. albicans, followed by L. casei Shirota, L. reuteri SD2112 and L. brevis CD2. None of the lactobacilli tested affected the growth of C. krusei. Only L. rhamnosus GG produced slight inhibitory effect on C. glabrata. The lower pH values led to larger inhibition zones. Sugar fermentation profiles varied between the strains. L. casei Shirota grew in the presence of all sugars tested, whereas L. brevis CD2 could utilise only glucose and fructose. All Candida species metabolised the available sugars but the most rapid growth was observed with C. glabrata. The results suggest that commercially available probiotics differ in their inhibitory activity and carbohydrate utilisation; the above properties are modified by different pH values and sugars with more pronounced inhibition at lower pH.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 688 | 289 | 33 |
| Full Text Views | 45 | 27 | 1 |
| PDF Views & Downloads | 27 | 12 | 3 |